Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Outstanding
Ratios

Alto Neuroscience (ANRO) Leases (2024 - 2026)

Alto Neuroscience has reported Leases over the past 3 years, most recently at $4.1 million for Q1 2026.

  • Quarterly results put Leases at $4.1 million for Q1 2026, down 16.2% from a year ago — trailing twelve months through Mar 2026 was $4.1 million (down 16.2% YoY), and the annual figure for FY2025 was $4.3 million, down 15.37%.
  • Leases reached $4.1 million in Q1 2026 per ANRO's latest filing, down from $4.3 million in the prior quarter.
  • Across five years, Leases topped out at $5.2 million in Q3 2024 and bottomed at $4.1 million in Q1 2026.
  • Median Leases over the past 3 years was $4.7 million (2025), compared with a mean of $4.6 million.
  • The largest annual shift saw Leases fell 14.25% in 2025 before it fell 16.2% in 2026.
  • Over 3 years, Leases stood at $5.0 million in 2024, then fell by 15.37% to $4.3 million in 2025, then dropped by 4.69% to $4.1 million in 2026.
  • Business Quant data shows Leases for ANRO at $4.1 million in Q1 2026, $4.3 million in Q4 2025, and $4.5 million in Q3 2025.